The Beatrice Hunter Cancer Research Institute logo
  • CRTP Integrated Learning Sessions

    Thursday, January 27, 2022

    • Time: 10:00 am - 12:00 pm
    • Location: MS Teams
    • Presenter: Dr. David Clarke and Dr. Kam Kafi
    • Topic: Artificial Intelligence

    The Beatrice Hunter Cancer Research Institute CRTP Integrated Learning Session (ILS) will be held on Thursday 27 January from 10:00am-12:00pm AST via MS Teams.

    Integrated Learning Sessions consist of presentations from various cancer research perspectives to better understand and address a topic. 

    ILS sessions are mandatory for CRTP Trainees – please contact admin@bhcri.ca if you are unable to attend. Trainees recognize the benefit of having supervisors in attendance at these sessions and we hope that all supervisors of CRTP trainees will attend as many sessions as possible.

    Topic: Artificial Intelligence

     

    Improving Neurosurgical Patient Care: The Interdependence of Research and Technology

    Presented by:

    Dr. David Clarke, MDCM, PhD, FRCSC, DABNS, FACS
    Professor and Head, Division of Neurosurgery, Dalhousie University and Nova Scotia Health

    The learning objectives are:
    •To understand neurosurgical considerations in offering a patient surgery
    •To understand the impact of research and technology in the surgical management of neurosurgical patients
    •To appreciate how innovation and research improves neurosurgical patient care

    Dr. David Clarke is a Professor within the Departments of Surgery (Neurosurgery & Otolaryngology), Medical Neuroscience, Medicine (Endocrinology), and Ophthalmology & Visual Sciences. He is Head of the Division of Neurosurgery, Dalhousie University and Nova Scotia Health, Halifax, Nova Scotia. He obtained his Doctor of Medicine degree from McGill University and completed his neurosurgical training at the Montreal Neurological Institute where he received the Penfield Award in Neurosurgery. He earned his PhD in neuroscience from McGill University, research that was supported by a Medical Research Council of Canada Fellowship. Dr. Clarke is a Fellow of the Royal College of Physicians and Surgeons of Canada. He is a Fellow of the American College of Surgeons. His clinical interests are predominantly in the areas of the management of pituitary and brain tumours, surgical treatment of epilepsy, and traumatic brain injury. He has special interest in the application of simulation technologies to neurosurgical education. Dr. Clarke performed the World’s first open brain surgery in a virtual reality environment for which he was awarded the National Research Council’s Outstanding Achievement Award for Canada. He has served as Vice-Chair of Canada’s Royal College Specialty Committee in Neurosurgery. He is Founder and Past Director of Canada’s first national Rookie Camp for new neurosurgical trainees. He is Co-Chair of the Halifax Neuropituitary Program. In 2020, Dr. Clarke performed the first-in-Canada robotic surgery using the Medtronic Stealth Autoguide TM. He has published over 85 peer-reviewed articles.

     

    AI in Cancer Research  - Overview of Challenges and Possibilities at Scale

    Presented by:

    Dr. Kam Kafi, MD CM
    Director of Clinical Strategy & Oncology, Imagia

    The learning objectives are:
    • Basic overview of AI: Domains, Technologies, Learning Paradigms
    • Using AI for the research process: Cohorting , Human in the loop annotations
    • Considerations in training models for Clinical use: Study design, concept drift, federated learning

    Kam is an impact-driven physician focused on bridging the gap between healthcare and computer sciences. With a background in cancer immunology, health information systems and artificial intelligence, he blends his medical degree and start-up background to materialize opportunities that can translate into AI-driven solutions at the intersection of patients and HCO’s. At Imagia, he oversees all clinical research projects with academic and industry partners. He focuses on growth strategy and product development, combining AI and digital therapeutics. A former cancer immunology researcher, Kam’s work focused on immuno-modulation and development of targeted immunotherapies, where he spent five years at UCLA in the Jonsson Comprehensive Cancer center with multiple publications. After co-founding several technology start-ups in media and healthcare, Kam sits as senior advisor at OutcomeMD, a company that delivers measurement-based care and outcome-driven decision support empowering a shift from patient catering to patient care. Kam holds degrees in Molecular, Cell, and Developmental Biology from UCLA, and a Medical Degree and training from McGill University.

     

    PLEASE NOTE: When joining a meeting, please ensure that your microphone and camera are enabled. Using Chrome or Microsoft Edge is recommended. It is important to mute mics when not in use so that background noise is minimal. For technical support please contact MedIT: CRichardson@Dal.Ca

    videoconference connection information will be sent to CRTP trainees and supervisors in advance via email. For all other members, if you are interested in joining this session, please contact admin@bhcri.ca 48 hours in advance for connection information.


Site by: Spectacle Group